|1.||Logemann, Jeri A: 4 articles (06/2009 - 04/2006)|
|2.||Chambers, Edgar: 3 articles (06/2010 - 01/2005)|
|3.||Gramigna, Gary D: 3 articles (06/2009 - 02/2008)|
|4.||McGarvey-Toler, Susan: 3 articles (06/2009 - 02/2008)|
|5.||Lindblad, Anne S: 3 articles (06/2009 - 02/2008)|
|6.||Gensler, Gary: 3 articles (06/2009 - 02/2008)|
|7.||Kosek, Steven: 3 articles (06/2009 - 02/2008)|
|8.||Lundy, Donna: 3 articles (06/2009 - 02/2008)|
|9.||Manson, Jessamyn S: 2 articles (03/2015 - 01/2010)|
|10.||Meyer, Scott: 2 articles (02/2015 - 06/2014)|
06/01/2014 - "The NECTAR-HF (NEural Cardiac TherApy foR Heart Failure) trial is designed to evaluate whether the Boston Scientific VNS device is safe and may attenuate cardiac remodelling, improve cardiac function and increase exercise capacity, in symptomatic heart failure patients (New York Heart Association Class II-III) with left ventricular systolic dysfunction (ejection fraction ≤35%) and receiving optimal medical therapy. "
06/01/2014 - "Rationale and study design of the NEuroCardiac TherApy foR Heart Failure Study: NECTAR-HF."
02/14/2015 - "Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) randomized controlled trial."
02/14/2015 - "Vagal nerve stimulation as delivered in the NECTAR-HF trial failed to demonstrate a significant effect on primary and secondary endpoint measures of cardiac remodelling and functional capacity in symptomatic heart failure patients, but quality-of-life measures showed significant improvement."
02/14/2015 - "The neural cardiac therapy for heart failure (NECTAR-HF) was a randomized sham-controlled trial designed to evaluate whether a single dose of vagal nerve stimulation (VNS) would attenuate cardiac remodelling, improve cardiac function and increase exercise capacity in symptomatic heart failure patients with severe left ventricular (LV) systolic dysfunction despite guideline recommended medical therapy. "
08/01/1997 - "An experiment was conducted to study the efficacy of two tomato pastes and aronia nectar (fruit juice + pulp from the black chokeberry, Aronia melanocarpa Elliot) as inhibitors of nitrosamine production in cancer prophylaxis programmes. "
02/01/2015 - "Search terms relating to deglutition or dysphagia or swallow and neoplasms and oncology or head and neck cancer and viscosity or texture and apira or residu* were combined with honey or nectar, xerostomia, and respiratory aspiration using Boolean operators. "
|3.||Melanoma (Melanoma, Malignant)
02/01/2009 - "Moreover, the improved performance of recruited bees in the PER paradigm suggests the occurrence of social learning of nectar scents inside the stingless bees' hives."
08/19/2014 - "These included pollen from corn and cotton, nectar from cotton, flowers from soybean, honey bees, Apis mellifera L., and pollen carried by foragers returning to hives, preplanting and in-season soil samples, and wild flowers adjacent to recently planted fields. "
12/22/2010 - "To select and establish floral biomarkers of the botanical origin of Diplotaxis tenuifolia honeys, the flavonoids and glucosinolates present in bee-deposited nectar collected from hive combs (unripe honey) and mature honey from the same hives fron which the unripe honey samples were collected were analyzed by LC-UV-PAD-ESI-MS(n). "
|5.||Parkinson Disease (Parkinson's Disease)
04/01/2002 - "All the patients were clinically assessed at least 3 months before and during a follow-up (for as long as 9 years) in accordance with the Core Assessment Program for Intracranial Transplantation (CAPIT) by a Russian group of the Network of European CNS Transplantation and Restoration (NECTAR) Programme by using the Unified Parkinson's Disease Rating Scale (URDRS). "
07/01/1999 - "In 1996, within the framework of NECTAR (Network for European CNS Transplantation and Restoration), a dedicated program entitled "Neurosurgical Interventions in Parkinson's Disease" (NIPD) was funded by the European Union Biomed 2 program to develop a new Core Assessment Program for Surgical Interventional Therapies in PD (CAPSIT-PD) and to establish an European registry for patients with PD subjected to functional neurosurgery. "
02/01/2008 - "This study was designed to identify which of 3 treatments for aspiration on thin liquids-chin-down posture, nectar-thickened liquids, or honey-thickened liquids-results in the most successful immediate elimination of aspiration on thin liquids during the videofluorographic swallow study in patients with dementia and/or Parkinson's disease. "
04/01/2008 - "To compare the effectiveness of chin-down posture and 2 consistencies (nectar or honey) of thickened liquids on the 3-month cumulative incidence of pneumonia in patients with dementia or Parkinson disease. "
04/01/2006 - "Ongoing RCTs in dysphagia are described including studies of (1) the effectiveness of the Shaker exercise versus standardized treatment in patients with severe dysphagia resulting from stroke or treatment for head and neck cancer who have been nonoral for at least three months; (2) the comparative effects of nectar- and honey-thickened liquids versus chin tuck posture and in patients with dementia or Parkinson's disease with or without dementia who aspirate on thin liquids; and (3) the comparative effects of muscle exercise versus sensory postural therapy for dysphagia resulting from treatment for head and neck cancer. "
|2.||Maharishi Amrit Kalash
|6.||Ascorbic Acid (Vitamin C)
|7.||salicylhydroxamic acid (SHAM)
|8.||Biological Markers (Surrogate Marker)
|10.||Sodium Dodecyl Sulfate (Sodium Lauryl Sulfate)
|1.||Vagus Nerve Stimulation
|2.||Transplantation (Transplant Recipients)
|4.||Traditional Medicine (Folk Remedies)
|5.||Enteral Nutrition (Feeding, Tube)